Literature DB >> 17067315

Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses.

Philipp Haselmayer1, Stefan Tenzer, Byoung S Kwon, Gundram Jung, Hansjörg Schild, Markus P Radsak.   

Abstract

In microbial infections polymorphnuclear neutrophils (PMN) constitute a major part of the innate host defence, based upon their ability to rapidly accumulate in inflamed tissues and clear the site of infection from microbial pathogens by their potent effector mechanisms. The recently described transmembrane receptor herpes virus entry mediator (HVEM) is a member of the tumour necrosis factor receptor super family and is expressed on many haematopoietic cells, including T cells, B cells, natural killer cells, monocytes and PMN. Interaction of HVEM with the natural ligand LIGHT on T cells has a costimulatory effect, and increases the bactericidal activity of PMN. To further characterize the function of HVEM on PMN, we evaluated the effect of receptor ligation on human PMN effector functions using an agonistic monoclonal antibody. Here we demonstrate that activation of HVEM causes activation of neutrophil effector functions, including respiratory burst, degranulation and release of interleukin-8 in synergy with ligands for Toll-like receptors or GM-CSF. In addition, stimulation via HVEM enhanced neutrophil phagocytic activity of complement opsonized, but not of non-opsonized, particles. In conclusion, these results indicate a new, as yet unknown, participation of HVEM in the innate immune response and points to a new link between innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067315      PMCID: PMC1819577          DOI: 10.1111/j.1365-2567.2006.02449.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  55 in total

Review 1.  Insights into programmed cell death through structural biology.

Authors:  S W Fesik
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils.

Authors:  I V Heinisch; I Daigle; B Knöpfli; H U Simon
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

3.  Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro.

Authors:  J Murray; J A Barbara; S A Dunkley; A F Lopez; X Van Ostade; A M Condliffe; I Dransfield; C Haslett; E R Chilvers
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

Review 4.  Death receptors: signaling and modulation.

Authors:  A Ashkenazi; V M Dixit
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 5.  Granules of the human neutrophilic polymorphonuclear leukocyte.

Authors:  N Borregaard; J B Cowland
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

Review 6.  Signals and receptors involved in recruitment of inflammatory cells.

Authors:  A Ben-Baruch; D F Michiel; J J Oppenheim
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

7.  Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.

Authors:  W C Liles; P A Kiener; J A Ledbetter; A Aruffo; S J Klebanoff
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 8.  Intracellular signaling in neutrophil priming and activation.

Authors:  G P Downey; T Fukushima; L Fialkow; T K Waddell
Journal:  Semin Cell Biol       Date:  1995-12

9.  ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival.

Authors:  H Schwarz; F J Blanco; J von Kempis; J Valbracht; M Lotz
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis.

Authors:  Astrid Alflen; Steve Prüfer; Katharina Ebner; Sebastian Reuter; Pamela Aranda Lopez; Inge Scharrer; Fumiaki Banno; Michael Stassen; Hansjörg Schild; Kerstin Jurk; Markus Bosmann; Hendrik Beckert; Markus P Radsak
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

3.  Antifungal Drugs Influence Neutrophil Effector Functions.

Authors:  Frederic Ries; Astrid Alflen; Pamela Aranda Lopez; Hendrik Beckert; Matthias Theobald; Hansjörg Schild; Daniel Teschner; Markus Philipp Radsak
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

4.  Blood transcriptome analysis revealing aging gene expression profiles in red panda.

Authors:  Jing Luo; Liang Zhang; Fujun Shen; Li Luo; Lei Chen; Zhenxin Fan; Rong Hou; Bisong Yue; Xiuyue Zhang
Journal:  PeerJ       Date:  2022-07-22       Impact factor: 3.061

5.  A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.

Authors:  Gerd Gladigau; Philipp Haselmayer; Inge Scharrer; Markus Munder; Nadine Prinz; Karl Lackner; Hansjörg Schild; Pamela Stein; Markus P Radsak
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

6.  A crucial role for HVEM and BTLA in preventing intestinal inflammation.

Authors:  Marcos W Steinberg; Olga Turovskaya; Raziya B Shaikh; Gisen Kim; Declan F McCole; Klaus Pfeffer; Kenneth M Murphy; Carl F Ware; Mitchell Kronenberg
Journal:  J Exp Med       Date:  2008-06-02       Impact factor: 14.307

7.  Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses.

Authors:  Astrid Alflen; Nicole Stadler; Pamela Aranda Lopez; Daniel Teschner; Matthias Theobald; Georg Heß; Markus P Radsak
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.